Olainfarm and Zdorovie.ru have become the winners in the…

Olainfarm and Zdorovie.ru have become the winners in the nomination “Digital Project of the Year” of the contest for the Eurasian Pharma Awards 2023 for the joint project “In the Rhythm of the Heart”.

The project enables cardiologists and patients with atrial fibrillation to remotely monitor the patient’s condition and ECG parameters for those undergoing antiarrhythmic therapy. This allows assessing the effectiveness and safety of pharmaceutical drugs therapy and enabling informed clinical decisions. The project was implemented by Olainfarm using Zdorovie.ru and Zdorovie.ru Doctor applications.

Andrey Moskvich, the General Director at Olainfarm Russia and Eric Brovko, the Founder and CEO at the Zdorovie.ru platform, were invited to receive awards.

Upon receiving the award, Andrey Moskvich highlighted: “This recognition means that we are heading in the right direction. It will motivate us to develop the project further and help more patients. This is the result of cooperative work of Olainfarm together with the cardiology community and our long-term partner, the Zdorovie.ru team”.

Eric Brovko emphasized: “For us, it is truly valuable to receive such an award because recognition motivates us to drive innovations. This partnership could not be successful without two important principles. First and foremost, it is trust that forms the basis of our relationships, and secondly, it is tolerance for mistakes and a culture of innovation that unites.

Uzbek pharmacy chain “OXYmed” is the winner in the…

Uzbek pharmacy chain “OXYmed” is one of the winners in the nomination “Pharmacy Chain of the Year” of the contest for the Eurasian Pharma Awards 2023.

The history of the pharmacy chain “OXYmed” dates back to 2003. Today, it includes 115 pharmacies, with over 80 of them located in Tashkent and the rest in various regions of the country. Over the years, a well-established network of suppliers has been developed. The supply chain from a supplier to a pharmacy is minimized, as “OXYmed” either directly collaborates with manufacturing plants or with large national companies. The pharmacy’s assortment includes not only a wide range of medicines but also herbal teas, dietary supplements, and beauty products.

Nargiza Madaliyeva, Interim CEO of the pharmacy chain “OXYmed”, upon receiving the award, thanked all the partners and clients without whom this victory would have been impossible.

Eurasian Pharma Awards 2023: Olainfarm and Meros Pharm are…

In 2023 in the competition for the Eurasian Pharma Awards in the nomination “Partnership of the Year” the award was presented to Olainfarm and Meros Pharm.

The transformation of collaboration between Olainfarm, a leading pharmaceutical company in the Baltics, and Meros Pharm, a leader in pharmaceutical distribution in Uzbekistan, along with increased investments in product promotion and improvements in both international and local logistics, has yielded tangible results that allow to develop ambitious plans for the future. The exclusive agreement has ensured the availability of Olainfarm products in over 4,000 pharmacies and has led to a 65% increase in sales compared to the previous year.

Elena Bushberg, Executive Director of Olainfarm, highlighted: «As a proverb says a tree is held by its roots, and a person is held by their family and heritage. I would add that success in business is held by good partners».

Stada is the winner in the nomination “Partnership of…

In 2023 in the competition for the Eurasian Pharma Awards in the nomination “Partnership of the Year” the award was given to the company Stada for the project in collaboration with Sanofi.

Stada and Sanofi have entered into a long-term agreement for the distribution of the CHC product portfolio in the Eurasian region. Since April of this year, Stada has been handling the distribution and marketing support for Sanofi’s products in 10 countries in the Eurasian region. The distribution agreement with Stada has strengthened its position as a leading company in the Consumer Healthcare segment in the region.

Arminas Macevicus, Vice President of Stada in the Eurasian region, highlighted: “This is an important recognition for us. I’d like to wish everyone to dream as when we dream big even the toughest negotiations lead to very positive solutions!”

Medservice Plus is the best distributor

The company “Medservice Plus” from Kazakhstan has become the winner in the nomination “Distributor of the Year” of the competition for the Eurasian Pharma Awards 2023.

“Medservice Plus” has been operating in the market of Kazakhstan for over 25 years and over these years has become a market leader having established itself as a reliable partner committed to providing customers with the highest quality medicines and innovative solutions. The company has developed partnerships with 350 producers worldwide, allowing it to supply over 7000 names of pharmaceutical drugs and medical products to the Kazakhstan market.

Saida Yerdenbekova, Member of the Board – Business Development Director at “Medservice Plus” emphasized the importance of recognizing the company’s work at the level of the Eurasian region and added that such competitions inspire further development and increase personnel motivation.

SANTO is the winner in nominations “Local Company of…

The Kazakh company SANTO, a member of the Polpharma Group of Companies, is the winner in 2 nominations of the contest for the Eurasian Pharma Awards 2023. The company has become the best in nominations “Local Company of the Year” and “Exporter of the Year”.

SANTO is a leading pharmaceutical company in Central Asia, its medicines portfolio includes more than 240 names in 12 pharmacotherapeutic groups. The company is implementing the major investment project to modernize existing pharmaceutical production facilities in accordance with the international GMP standards, which financing has already amounted to around 108 million dollars.

SANTO supplies effective, safe and high quality pharmaceutical drugs to the market of Kazakhstan; the company’s products are exported to Kyrgyzstan, Uzbekistan, Russia, Mongolia, Turkmenistan and Tajikistan. At the moment, SANTO is exploring opportunities for export of medicines to Afghanistan. In 2022 the share of export from total sales exceeded 25%. The market of Kyrgyzstan especially stands out – since the opening of the representative office there in 2015 the company’s position reached the leading place in this country. So SANTO is currently number one not only in Kazakhstan but also in Kyrgyzstan. Uzbekistan also demonstrates an increase in sales.

Managing Director of SANTO Adam Aleksiejuk and Country Manager of SANTO in Uzbekistan Mirolim Fayziev were invited to the stage to receive awards.

Adam Aleksiejuk thanked the organizers for the opportunity to participate in such a large-scale event and highlighted: “At SANTO, we consider Central Asia as the most promising region for the Polpharma Group of Companies and undoubtedly we see Uzbekistan as the country with the prospects for future growth”.

Mirolim Fayziev emphasized: “Indeed, in Kazakhstan SANTO is the largest local company and a major exporter. Rapidly developing Uzbekistan is very attractive for investors. I hope that in the future the company will be localized in Uzbekistan as well and will become not only an importer but also a large exporter”.

NIKA PHARM is the “Local Company of the Year”

Uzbek company NIKA PHARM has become the winner in the nomination “Local Company of the Year” at the Eurasian Pharma Awards 2023 contest.

NIKA PHARM is consistently among the top three local producers in Uzbekistan. The company has already registered more than 100 pharmaceutical drugs and 37 dietary supplements. The company’s products are promoted both in the Uzbek market and overseas. NIKA PHARM is continuously working to improve product quality, and confirmation by international inspections open the gateway for them to new markets. Agreements with the European Bank for Reconstruction and Development further validate NIKA PHARM’s status as a steadily developing company.

Sergey Kim, CEO of NIKA PHARM, expressed his gratitude to the organisers for the opportunity to participate in such a high-level event and thanked them for the awards and received recognition.

Solgar is the “International Company of the Year”

Solgar has become the winner of the competition for the Eurasian Pharma Awards 2023 in the nomination “International Company of the Year”.

Solgar has been producing unique premium dietary supplements for over 75 years. Today, company’s products are presented in more than 65 countries around the world, the product range includes more than 600 names. The company has been operating in the markets of the Eurasia region for 15 years and continues to expand its presence, fulfilling a global mission to develop a culture of nutrient responsible consumption among the population and educate the medical and pharmaceutical community.

CEO of Solgar Russia & CIS Hakan Erturk receiving the award thanked the organisers for the opportunity to speak to a high-level audience at the Eurasian Pharmaceutical Summit, held by the Global Pharmaceutical Leaders’ Club, and discuss issues in the pharmaceutical markets of Eurasia region and prospects for the development of the dietary supplement segment.

Top managers of Meros Pharm are “Leaders of the…

Top managers of Meros Pharm, founder Nasim Komilov and CEO Hayyom Sharapov have become the winners of the contest for the Eurasian Pharma Awards 2023 in the nomination “Leader of the Year”.

The competition for the Eurasian Pharma Awards was held for the fourth time by the Global Pharmaceutical Leaders’ Club as a part of the Eurasian Pharmaceutical Summit. 97 applications for awards were received from pharmaceutical production companies, distributors and pharmacy chains.

Meros Pharm has been providing citizens of the Republic of Uzbekistan with medicines for 15 years and has become the market leader with a share of more than 30%. The portfolio of Meros Pharm includes medicines from more than 400 suppliers. The company provides jobs to more than 1200 Uzbek people, who are proud of their involvement in supporting the health of their compatriots.

ASKLEPIY Distribution is the winner in the “Digital Project…

ASKLEPIY Distribution was the winner of the Eurasian Pharma Awards 2022 in the nomination “Digital Project of the Year” for the project “Automation of the full cycle of business processes of the commercial departments of a distribution company”.

The implementation of the project allowed achieving a complete reorganization of category management departments, more than doubling the turnover of goods, significantly reducing missed sales opportunities, and increasing the attractiveness of the price list in the eyes of consumers.

Said Talibov, CEO of the ASKLEPIY Group of companies, upon receiving the award, noted: “IT is our future, therefore we are moving in this direction. With IT products, the transformation of the pharmaceutical industry in Uzbekistan has started”. The competition for the Eurasian Pharma Awards will be held for the 4th time in 2023 as a part of the Eurasian Pharmaceutical Summit. In 2023, applications are accepted until the 18th August. The winners of the competition will be announced at the Eurasian Pharmaceutical Summit on the 26th September. Do not miss the chance to tell your peers in the pharmaceutical market and the public about the success of your company!